Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.
about
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaExtranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy.Outcomes of dose-adjusted Berlin-Frankfurt-Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma.Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China.Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapyCD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cellsL-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphomaA prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trialHigh post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.PD-1 expression on the surface of peripheral blood CD4(+) T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma.Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma.Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project.Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy.Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification.Extranodal Natural Killer/T-Cell Lymphoma in Children and Adolescents: A Report of 17 Cases in China.Clinical analysis of 1629 newly diagnosed malignant lymphomas in current residents of Sichuan province, China.Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-ceGenetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012.Classic Hodgkin lymphoma in pelvis: A case report highlights diagnosis and treatment challenges.Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.Hematologic malignancies in elderly patients.
P2860
Q27314809-C01A4771-983C-4869-8C91-53AF5E07589EQ28070073-99FECEF0-E4E0-496E-A04D-FFA920457743Q30244110-8E7F308E-B6A4-4A4F-A66B-79F6D6B63D30Q33423854-9F493EB7-FE4D-4A55-AF9D-DFF55CDD7E71Q33429990-A1668AAD-EDB8-42DF-BF81-D6B6EF39C52EQ33841441-8625E3D0-F2D7-4EE0-90EC-0C80772C8EECQ33935351-9A9559E3-DA1B-4DAB-86F5-911866BD7290Q35145308-E9E89456-0BB7-466E-B0B3-5DCE2E75A190Q35147984-8506CA18-7632-4E11-932D-1EB4182ADBDBQ35159889-4422A417-5728-49A3-B3B4-C09390E7AC76Q35919295-D8C14C79-6612-4CE5-A2BE-95E4DCD8C887Q36078298-4FB8FCAF-3BD2-4E52-ADC8-7525F49933B0Q36192295-D1BF93E9-E3C6-4A07-B28E-694C0C2D57A8Q36954142-D81A50D2-8E8B-4B40-8083-9339C2E845B4Q37071962-8BA36373-83B6-4CA6-87C7-4D3E56C2751DQ37304125-047DD302-0789-44F0-9461-568F05170B94Q37362703-691D831E-287A-41D8-8727-7DC760AC859BQ37362830-F1A78380-A4AB-42EA-AD61-B1553A3C0F34Q37429917-C1FA9A70-5DD8-4589-BF5B-F24A3B085545Q37581977-A3778DF5-76B5-487B-B82A-23FD184A1617Q37602246-FAD5F6D5-D322-49E5-B230-6171CD5389D4Q37697320-CA34C01D-2D5F-4ECA-8CAC-95900F7FB0E6Q37706167-B5A7706A-91A0-4929-A770-D72FF09B2F6FQ38625454-EAFD9F58-AD8C-4D08-A6C4-53E39308C7DCQ38653148-A1CC85DE-5C1C-4545-9FA6-B0706F27E073Q38674038-EDB09E7B-3A9E-4FB8-82E5-22448E557B89Q40089985-BEDF3383-E816-43A0-9C8F-BC9F17ECDB84Q40128026-4869512E-1A2E-4227-B717-D5ABB4F3D37DQ40922483-AA22151B-532F-47FB-948E-605DD4D52BC3Q40985436-D1E9704E-68B6-4B9B-9ED3-119E37BD5CEBQ41014498-E604D649-2837-4DEF-9912-8A4A70018D61Q41138924-59478297-BE78-44EE-8336-E7D4EC895814Q41387447-E399A536-D3F3-4C4D-B5D3-897D96C77005Q41472982-EA4388BE-35E9-4355-A7F5-EB29F9F1F180Q41544357-28757C5F-D1AB-4E41-8F19-EF2EE3755459Q41681723-A757933A-6955-4F88-902F-8D35A9E1CACCQ41928797-04F88247-0414-4BDA-B5F7-53AB9F80D39FQ42316356-AD4AFECB-196D-43D0-99BC-99F066C2C77BQ42333509-64A11B29-5B48-4737-AD80-EC40605B68FFQ42716194-58659AA9-4708-45E5-99C4-4C16FC984BA3
P2860
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Distribution of lymphoid neopl ...... h Organization classification.
@en
Distribution of lymphoid neopl ...... h Organization classification.
@nl
type
label
Distribution of lymphoid neopl ...... h Organization classification.
@en
Distribution of lymphoid neopl ...... h Organization classification.
@nl
prefLabel
Distribution of lymphoid neopl ...... h Organization classification.
@en
Distribution of lymphoid neopl ...... h Organization classification.
@nl
P2093
P2860
P356
P1476
Distribution of lymphoid neopl ...... h Organization classification.
@en
P2093
Cuiling Liu
Miaoxia He
P2860
P304
P356
10.1309/AJCP7YLTQPUSDQ5C
P407
P577
2012-09-01T00:00:00Z